tiprankstipranks
Trending News
More News >
Transcenta Holding Limited (HK:6628)
:6628
Hong Kong Market
Advertisement

Transcenta Holding Limited

Compare
3 Followers

6628 Stock Chart & Stats

HK$3.57
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$3.57
HK$0.00(0.00%)

Transcenta Holding Limited News

6628 FAQ

What was Transcenta Holding Limited’s price range in the past 12 months?
Transcenta Holding Limited lowest stock price was HK$0.50 and its highest was HK$5.80 in the past 12 months.
    What is Transcenta Holding Limited’s market cap?
    Transcenta Holding Limited’s market cap is HK$1.35B.
      When is Transcenta Holding Limited’s upcoming earnings report date?
      Transcenta Holding Limited’s upcoming earnings report date is Mar 26, 2026 which is in 144 days.
        How were Transcenta Holding Limited’s earnings last quarter?
        Transcenta Holding Limited released its earnings results on Aug 27, 2025. The company reported -HK$0.295 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.295.
          Is Transcenta Holding Limited overvalued?
          According to Wall Street analysts Transcenta Holding Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Transcenta Holding Limited pay dividends?
            Transcenta Holding Limited does not currently pay dividends.
            What is Transcenta Holding Limited’s EPS estimate?
            Transcenta Holding Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Transcenta Holding Limited have?
            Transcenta Holding Limited has 452,075,500 shares outstanding.
              What happened to Transcenta Holding Limited’s price movement after its last earnings report?
              Transcenta Holding Limited reported an EPS of -HK$0.295 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.466%.
                Which hedge fund is a major shareholder of Transcenta Holding Limited?
                Currently, no hedge funds are holding shares in HK:6628

                Transcenta Holding Limited Stock Smart Score

                9
                Outperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                233.33%
                12-Months-Change

                Fundamentals

                Return on Equity
                -34.18%
                Trailing 12-Months
                Asset Growth
                -28.12%
                Trailing 12-Months

                Company Description

                Transcenta Holding Limited

                Transcenta Holding Limited (6628) is a biopharmaceutical company focused on the discovery, development, and manufacturing of innovative therapeutics. The company operates primarily in the healthcare sector, with a core emphasis on antibody-based biologics. Transcenta's portfolio includes a pipeline of proprietary biologic candidates targeting cancer, bone and kidney diseases, and other serious medical conditions.

                Transcenta Holding Limited (6628) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Kintor Pharmaceutical Ltd
                TOT BIOPHARM International Co. Ltd.
                Clover Biopharmaceuticals Ltd.
                Sirnaomics Ltd.
                SinoMab Bioscience Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis